Want to see DE:2HRA full AI Analyst Report?
Top Page
H&R GmbH & Co. KGaA
(XETRA:2HRA)
Select Model
Select Model
Rating:60Neutral
Price Target:
€7.50
▲(17.92% Upside)
Action:Reiterated
Date:08/19/26
The score is primarily driven by improving financial performance in TTM (revenue and margin rebound, back to profitability) but capped by very thin net margins and a sharp free-cash-flow decline. Technicals are supportive with an uptrend across key moving averages and moderate momentum. Valuation is a significant drag due to the very high P/E versus current earnings quality and only a modest dividend yield.
Positive Factors
Operational recovery
The TTM recovery shows that H&R has regained operating traction after the weaker 2025 period. Higher revenue and EBIT margin indicate improving utilization and product economics, creating a stronger base for sustained profitability if industrial demand and specialty-product spreads remain supportive.
Negative Factors
Very thin net profitability
The very low net margin leaves little room for weaker pricing, higher costs, or softer industrial demand to affect reported earnings. Even with operating improvement, limited bottom-line conversion means modest disruptions can materially reduce profitability and constrain internally funded growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Operational recovery
The TTM recovery shows that H&R has regained operating traction after the weaker 2025 period. Higher revenue and EBIT margin indicate improving utilization and product economics, creating a stronger base for sustained profitability if industrial demand and specialty-product spreads remain supportive.
Read all positive factors
H&R GmbH & Co. KGaA (2HRA) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€249.39M
Dividend Yield1.49%
Average Volume (3M)5.25K
Price to Earnings (P/E)114.0
Beta (1Y)0.46
Revenue Growth-2.00%
EPS Growth-68.70%
CountryDE
Employees1,688
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.06
Shares Outstanding37,221,745
10 Day Avg. Volume5,302
30 Day Avg. Volume5,248
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.43
Price to Sales (P/S)0.13
P/FCF Ratio4.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.29
Revenue Forecast (FY)€1.40B
H&R GmbH & Co. KGaA Business Overview & Revenue Model
Company Description
H&R GmbH & Co. KGaA is a German enterprise specializing in the production and distribution of chemical-pharmaceutical raw materials and precision plastic components, manufactured through injection molding. The company's operations are structured i...
How the Company Makes Money
H&R makes money primarily by manufacturing and selling specialty refinery products and chemical specialties. Its revenue model is largely volume-driven and margin-driven: it purchases crude oil and other hydrocarbon feedstocks, processes them in i...
H&R GmbH & Co. KGaA Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
63
Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.30B | 1.24B | 1.34B | 1.35B | 1.58B | 1.19B |
| Gross Profit | 133.30M | 120.37M | 121.06M | 115.78M | 155.57M | 143.55M |
| EBITDA | 113.27M | 69.19M | 91.69M | 88.33M | 123.76M | 131.35M |
| Net Income | 2.55M | -38.80M | 10.62M | 10.56M | 42.71M | 50.18M |
Balance Sheet | ||||||
| Total Assets | 1.03B | 950.42M | 1.01B | 903.24M | 962.07M | 874.38M |
| Cash, Cash Equivalents and Short-Term Investments | 69.45M | 70.96M | 64.01M | 69.44M | 55.89M | 48.92M |
| Total Debt | 166.07M | 183.09M | 194.60M | 202.61M | 244.24M | 196.28M |
| Total Liabilities | 562.50M | 534.34M | 546.26M | 445.62M | 490.91M | 465.90M |
| Stockholders Equity | 425.46M | 375.64M | 426.86M | 413.02M | 423.64M | 362.60M |
Cash Flow | ||||||
| Free Cash Flow | 14.24M | 37.53M | 15.23M | 61.42M | -32.04M | -11.59M |
| Operating Cash Flow | 70.98M | 93.14M | 70.24M | 119.07M | 37.98M | 37.42M |
| Investing Cash Flow | -60.14M | -57.73M | -54.45M | -56.26M | -72.46M | -48.56M |
| Financing Cash Flow | -4.53M | -23.57M | -25.80M | -46.94M | 41.51M | 2.48M |
H&R GmbH & Co. KGaA Technical Analysis
Positive
6.36
Price Trends
6.82
Positive
6.10
Positive
5.23
Positive
Market Momentum
0.02
Positive
47.14
Neutral
25.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:2HRA, the sentiment is Positive. The current price of 6.36 is below the 20-day moving average (MA) of 7.25, below the 50-day MA of 6.82, and above the 200-day MA of 5.23, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 47.14 is Neutral, neither overbought nor oversold. The STOCH value of 25.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:2HRA.
H&R GmbH & Co. KGaA Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | €5.41B | 17.04 | 17.00% | 2.78% | 5.53% | 17.05% | |
64 Neutral | €9.95B | 82.60 | 1.49% | 4.68% | -4.03% | -71.46% | |
60 Neutral | €249.39M | 114.00 | 0.64% | 1.49% | -2.00% | -68.70% | |
57 Neutral | €4.42B | -10.08 | -11.14% | 2.81% | ― | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
48 Neutral | €1.10B | -1.64 | -18.62% | 0.79% | -9.81% | -305.46% |
* General Sector Average
DE:2HRA
H&R GmbH & Co. KGaA
6.70
1.78
36.18%
DE:EVK
Evonik
21.36
7.77
57.19%
DE:FPE3
Fuchs Petrolub
44.30
6.97
18.67%
DE:LXS
LANXESS
12.69
-7.53
-37.25%
DE:WCH
Wacker Chemie AG
89.00
23.50
35.88%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.